| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 528,001 | 508,209 | 456,940 | 561,477 | | Cost of Revenue | 364,007 | 344,356 | 323,314 | 407,174 | | | Gross Profit | 163,994 | 163,853 | 133,626 | 154,303 | | | Operating Expenses | | Research Development | 18,497 | 21,886 | 17,889 | 19,923 | | Selling General and Administrative | 58,928 | 71,796 | 43,309 | 73,427 | | Non Recurring |
-
| 14,647 |
-
| 279 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 86,569 | 55,524 | 72,428 | 60,674 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,017) | 1,296 | (1,559) | (15,995) | | Earnings Before Interest And Taxes | 85,552 | 56,820 | 70,869 | 44,679 | | Interest Expense | 6,663 | 6,689 | 7,155 | 7,464 | | Income Before Tax | 78,889 | 50,131 | 63,714 | 37,215 | | Income Tax Expense | 17,864 | 17,851 | 17,847 | 12,222 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 61,025 | 32,280 | 45,867 | 24,993 | | | Non-recurring Events | | Discontinued Operations | 273 | 2,921 | 30 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 61,298 | 35,201 | 45,897 | 24,993 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $61,298 | $35,201 | $45,897 | $24,993 |
|
0.51% Nasdaq 
Income Statement
